Pharmaceutical Misrepresentation

Pharmaceutical Misrepresentation is a form of deceptive trade practice in which a pharmaceutical entity intentionally or negligently communicates false or misleading information about a drug’s safety, efficacy, or intended use, thereby distinguishing it from other regulatory violations by its reliance on falsity or omission in commercial speech to influence prescribers, patients, or regulatory bodies.

17

Publications

2.2K

Citations

24

Authors

8

Institutions

Publications per year

2017–2026

1

Authors

24

  1. AB
    Alison Bass

    1 publications · 132 citations

    1

    h-index

  2. JL
    Joel Lexchin

    York University, Canada

    1 publications · 40 citations

    1

    h-index

  3. PJ
    P. J. M. M. Toll’s-Hertogenbosch

    1 publications · 143 citations

    1

    h-index

  4. VC
    Valéria C. Rolla

    Fundação Oswaldo Cruz, Brazil

    1 publications · 204 citations

    1

    h-index

  5. VT
    Valerio Temperini

    Marche Polytechnic University, Italy

    1 publications · 13 citations

    1

    h-index

1–5 of 24

Venues

  1. BMJ

    2 publications · 169 citations

    2

    h-index

  2. Choice Reviews Online

    CRO · 2 publications · 913 citations

    2

    h-index

  3. Journal of Vascular Surgery

    1 publications · 27 citations

    1

    h-index

  4. Medisch-Farmaceutische Mededelingen

    MFM · 1 publications · 143 citations

    1

    h-index

  5. The Journal of Law Medicine & Ethics

    JLME · 1 publications · 40 citations

    1

    h-index

1–5